Senior insider sale
General Counsel at KALARIS THERAPEUTICS, INC. — senior position signals high conviction
$2.9K
188.00 shares
What this filing means
MILLER EDWARD plans to sell 188.00 shares of KALARIS THERAPEUTICS, INC. valued at approximately $2.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/24/2025ACC: 0000950170-25-008728
Officer· General Counsel
Since Jul 2020
188.00
Shares to sell
$2.9K
Approx. market value
52.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock
N/A
1/23/2025
52.00Total acquired52.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2025 | Restricted Stock N/A | 52.00 | — |
| Total | 52.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
18.00
Market value
$180.00
1/10/2025
—Completed
Units to sell
19.00
Market value
$235.00
11/19/2024
—Completed
Units to sell
99.00
Market value
$2.0K
11/5/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
52.00
Market value
$495.00
1/23/2025
Total
Units
188.00
Value
$2.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/10/2025 | 18.00 | $180.00 | — | Completed |
11/19/2024 | 19.00 | $235.00 | — | Completed |
11/5/2024 | 99.00 | $2.0K | — | Completed |
| Planned — Approximate Date | ||||
1/23/2025 | 52.00 | $495.00 | NASDAQ | Planned |
| Total | 188.00 | $2.9K | ||